News
Novo Nordisk has launched its popular weight-loss drug Wegovy in Thailand, marking its first entry into the Southeast Asian ...
Novo Nordisk has launched its hugely popular weight-loss drug Wegovy in Thailand, an executive of the Danish drugmaker's ...
Weight loss injections can be useful aids for people who are struggling to shed unwanted pounds. GLP-1 agonist jabs, like Mounjaro and Wegovy, reduce people’s appetites. They can also slow down the ...
Novo Nordisk, a leading global healthcare company, has announced the signing of a MoU with Lifera, a biopharmaceutical company owned by the Saudi sovereign wealth fund PIF (Public Investment Fund), to ...
President Donald Trump is under pressure to decide how widely available anti-obesity drugs should be and whether Medicare should cover them.
Years ago, Robyn Munsch would wander hungrily around the grocery store and leave with calorie-dense foods like a frozen pizza ...
Novo Nordisk remains financially strong, but pricing pressures and CagriSema challenges limit near-term upside. Find out why ...
This week in Ozempic news: No more compounded GLP-1s, weight-loss pills are coming, and WeightWatchers is filing for ...
The Lessie B. Price Center advertised their fitness programs for seniors and educational programs for youth at their open ...
The Columbia County Spring Fair is back in town, but this time with some policy changes amid disruptions last week.
Novo Nordisk scored a legal win against compounders of its blockbuster GLP-1 drugs. But it may not end the copycats.
The court ruled in favor of Novo Nordisk and the FDA, rejecting a compounding pharmacy group's attempt to stop the FDA's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results